Velocity is using multimodal LLMs, like OpenAI’s GPT-4o and others, to enhance productivity. At the forefront of this shift is Raghu Punnamraju, Velocity’s Chief Technology Officer. In this article he shares his thoughts on the rapid evolution of LLMs, and how quickly new tools are … Read more
Enjoy a virtual tour of Velocity’s Durham, NC site, which showcases many of the features and standard equipment present at Velocity sites worldwide. Standard Velocity site features: Private exam rooms Comfortable patient reception areas Facilities for extended-stay PK studies Ample parking Secure monitoring rooms … Read more
“Next to clean water, vaccines are probably responsible for more saved lives than anything else we’ve done in medicine.” -Mark Turner, MD, Vaccine CARE Council Leader and Velocity Principal Investigator in Boise, ID. Given the constant evolution of viruses and the massive medical and … Read more
Beth Safirstein, MD, leads a site that was recently recognized by a top 10 pharma Sponsor as a leading U.S. enroller of diverse patients. As the chair of the CNS CARE Council, Dr. Safirstein is one of the expert Principal Investigators who will inform … Read more
In the second of two blogs in a collaborative series written by Paul Evans, President and CEO, and Victoria DiBiaso, Head, Patient Informed Development & Health Value Translation, Sanofi, they emphasize the most critical aspect of clinical trials — the patient. As we blaze … Read more
“Clinical research is really the only opportunity we have to give our patients some hope and some perspective that their disease will one day be treatable.” Nadege Gunn, MD, CPI, has consistently championed community engagement and physician referrals to drive successful clinical trial enrollment … Read more
Congratulations to Paul Evans, President and CEO of Velocity, for being named one of the most influential life sciences business leaders in the state in Business North Carolina’s 2024 Power List! The list was compiled by BNC’s editorial team after seeking nominations, talking with … Read more
Merck recently presented Velocity’s Hallandale Beach site with the Significant Contribution to Clinical Trials Award, specifically for being the top enroller of diverse participants in cardiovascular clinical trials in 2023. We’re grateful for the contributions of our Hallandale Beach site toward improving diversity in … Read more
Velocity recently asked some key employees to come together and discuss a wide array of issues impacting diversity, equity, and inclusion (DEI) in trials. Velocity’s ongoing goals are to share best practices, identify and address shortcomings, and bring as many perspectives and viewpoints to … Read more
To celebrate the upcoming Clinical Trials Day and the ‘Trailblazers Among Us’ theme, Paul Evans, President and CEO of Velocity, and Victoria DiBiaso, Head, Patient Informed Development & Health Value Translation at Sanofi, have coauthored this article. In the post, they review several of … Read more
Shishir Khetan, MD, is a Principal Investigator and Senior Medical Director at Velocity. He’s also a leading expert for the Cardiometabolic CARE Council. But as he explains in this video, he’s excited about the opportunities the CARE Council model is creating for investigators. Through … Read more
Heart disease remains the leading cause of death worldwide. The proliferation of heart issues — paired with lifestyle factors that complicate patient recruitment and study design — reflect an urgent need for expert-led clinical trials. Moreover, intersections among heart health and metabolic research offer … Read more
Learn more about Velocity's capabilities
Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.
Join a remarkable team doing remarkable work
Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.
Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.